Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AC Immune S.A. (NQ: ACIU )

2.850 -0.050 (-1.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,948
Open 2.880
Bid (Size) 2.800 (11)
Ask (Size) 3.320 (30)
Prev. Close 2.900
Today's Range 2.840 - 2.930
52wk Range 1.680 - 3.830
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
From AC Immune SA
Via GlobeNewswire
AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
From AC Immune SA
Via GlobeNewswire

Performance

YTD
+28.96%
+28.96%
1 Month
-12.31%
-12.31%
3 Month
-2.06%
-2.06%
6 Month
+26.11%
+26.11%
1 Year
-9.81%
-9.81%

More News

Read More
AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023
From AC Immune SA
Via GlobeNewswire
AC Immune SA Appoints New Chief Medical Officer
From AC Immune SA
Via GlobeNewswire
Why Shares of AC Immune Jumped This Week
Via The Motley Fool
Why AC Immune Stock Skyrocketed Today
Via Benzinga
AC Immune Earnings Preview
Via Benzinga
AC Immune Showcasing Precision Medicine Programs at AAIC 2023
From AC Immune SA
Via GlobeNewswire
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease
From AC Immune SA
Via GlobeNewswire
AC Immune Holds Annual General Meeting of Shareholders
From AC Immune SA
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update
From AC Immune SA
Via GlobeNewswire
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s Disease
From AC Immune SA
Via GlobeNewswire
AC Immune at AD/PD™ 2023 to Present New Clinical and Preclinical Data from its Precision Medicine Pipeline
From AC Immune SA
Via GlobeNewswire
AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update
From AC Immune SA
Via GlobeNewswire
AC Immune to Report Full Year 2022 Financial Results and Provide Corporate Update on March 16, 2023
From AC Immune SA
Via GlobeNewswire
AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43
From AC Immune SA
Via GlobeNewswire
AC Immune to Present at the SVB Securities Global Biopharma Conference
From AC Immune SA
Via GlobeNewswire
AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial
From AC Immune SA
Via GlobeNewswire
AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease
From AC Immune SA
Via GlobeNewswire
AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development
From AC Immune SA
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.